$LLY: Eli Lilly Q3 Adj. EPS $7.48 vs $5.59 est., Raises FY Revenue Guidance

$LLY

$LLY – Eli Lilly Q3 Adj. EPS $7.48 vs $5.59 est., Raises FY Revenue Guidance

2026-10-29 10:48:26 UTC · TELEGRAM · All $LLY

?? Positive AI Sentiment (+6.8 / 10)

Q3 revenue reached $24.40B (est. $22.52B), Adj. EPS of $7.48 easily beat $5.59 consensus.
Blockbuster drugs Mounjaro ($10.7B) and Zepbound ($5.35B) beat market expectations.
FY revenue guidance raised to $91B-$92B (prior $85B-$87B); FY Adj. EPS guided to $35-$36 (prior $35.50-$36.50).

Observed market reaction after signal

4h +6.64% · Peak +9.32%